Author Correction: A second-generation M1-polarized CAR macrophage with antitumor efficacy

Affiliations

• ¹ Center for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
• ² Liangzhu Laboratory, Zhejiang University, Hangzhou, China.
• ³ Institute of Hematology, Zhejiang University, Hangzhou, China.
• ⁴ CellOrigin Inc, Hangzhou, China.
• ⁵ School of Basic Medical Sciences, Nanchang University, Nanchang, China.
• ⁶ Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
• ⁷ Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
• ⁸ Eye Center of the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Provincial Key Lab of Ophthalmology, Hangzhou, China.
• ⁹ MOE Frontier Science Center for Brain Science and Brain-machine Integration, State Key Laboratory of Brain-machine Intelligence, Zhejiang University, Hangzhou, China.
• ¹⁰ NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University, Hangzhou, China.
• ¹¹ Department of Genetics and Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, MA, USA.
• ¹² Center for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [email protected].
• ¹³ Liangzhu Laboratory, Zhejiang University, Hangzhou, China. [email protected].
• ¹⁴ Institute of Hematology, Zhejiang University, Hangzhou, China. [email protected].
• ¹⁵ Center of Gene and Cell Therapy and Genome Medicine of Zhejiang Province, Hangzhou, China. [email protected].